Motivations of Patients With Pulmonary Arterial Hypertension to Participate in Randomized Clinical Trials

Clinical Trials - United Kingdom
doi 10.1177/1740774512438981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Why Community Physicians Should Encourage Their Patients to Participate in Randomized Clinical Trials

Circulation
Cardiovascular MedicinePhysiologyCardiology
1978English

Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Platelet Indices in Patients With Pulmonary Arterial Hypertension

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2011English

Pulmonary Arterial Hypertension in Patients Treated With Interferon

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Single Arterial Occlusion to Locate Resistance in Patients With Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Pulmonary Arterial Hypertension in Patients With Primary Sjögren’s Syndrome

Autoimmune Diseases
AllergyImmunologyMicrobiology
2014English

Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension

Therapeutic Advances in Chronic Disease
Medicine
2018English

Reasons for Accepting or Declining to Participate in Randomized Clinical Trials for Cancer Therapy

British Journal of Cancer
Cancer ResearchOncology
2000English

DOs Encouraged to Participate in Pharmaceutical, Clinical Trials

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy